The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity
Open accessAbstract
NK cells are a major component of the antitumor immune response and are involved in controlling tumor progression and metastases in animal models. Here, we show that dysfunction of these cells accompanies human breast tumor progression. We characterized human peripheral blood NK (p-NK) cells and malignant mammary tumor-infiltrating NK (Ti-NK) cells from patients with noninvasive and invasive breast cancers. NK cells isolated from the peripheral blood of healthy donors and normal breast tissue were used as controls. With disease progression, we found that expression of activating NK cell receptors (such as NKp30, NKG2D, DNAM-1, and CD16) decreased while expression of inhibitory receptors (such as NKG2A) increased and that this correlated with decreased NK cell function, most notably cytotoxicity. Importantly, Ti-NK cells had more pronounced impairment of their cytotoxic potential than p-NK cells. We also identified several stroma-derived factors, including TGF-β1, involved in tumor-induced reduction of normal NK cell function. Our data therefore show that breast tumor progression involves NK cell dysfunction and that breast tumors model their environment to evade NK cell antitumor immunity. This highlights the importance of developing future therapies able to restore NK cell cytotoxicity to limit/prevent tumor escape from antitumor immunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
Complex networks orchestrate epithelial–mesenchymal transitions
Thiery, J. P., & Sleeman, J. P. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1835 · Cited by 3,958
Functions of natural killer cells
Vivier, E., Tomasello, E., Baratin, M., Walzer, T., & Ugolini, S. (2008) · Nature Immunology · doi:10.1038/ni1582 · Cited by 3,943
Rosenwald, A., Wright, G., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne, R. D., Muller-Hermelink, H. K., Smeland, E. B., Giltnane, J. M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012914 · Cited by 3,829
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684
Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis
Yang, J., & Weinberg, R. A. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.05.009 · Cited by 3,012
Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 2,999
The biology of human natural killer-cell subsets
Cooper, M. A., Fehniger, T. A., & Caligiuri, M. A. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02060-9 · Cited by 2,975
Biology of Natural Killer Cells
Trinchieri, G. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60664-1 · Cited by 2,902
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., & Schreiber, R. D. (2001) · Nature · doi:10.1038/35074122 · Cited by 2,896
Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis
Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., Biassoni, R., & Moretta, L. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.197 · Cited by 1,778
Self-citationStromal gene expression predicts clinical outcome in breast cancer
Finak, G., Bertos, N., Pepin, F., Sadekova, S., Souleimanova, M., Zhao, H., Chen, H., Omeroglu, G., Meterissian, S., Omeroglu, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1764 · Cited by 1,687
Lanier, L. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.359 · Cited by 1,648
Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice
Kaplan, D. H., Shankaran, V., Dighe, A. S., Stockert, E., Aguet, M., Old, L. J., & Schreiber, R. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7556 · Cited by 1,465
Swann, J. B., & Smyth, M. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31405 · Cited by 1,447
Tumor-Infiltrating CD8+Lymphocytes Predict Clinical Outcome in Breast Cancer
Mahmoud, S. M. A., Paish, E. C., Powe, D. G., Macmillan, R. D., Grainge, M. J., Lee, A. H. S., Ellis, I. O., & Green, A. R. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.5037 · Cited by 1,367
Migrating cancer stem cells — an integrated concept of malignant tumour progression
Brabletz, T., Jung, A., Spaderna, S., Hlubek, F., & Kirchner, T. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1694 · Cited by 1,352
Guy, C. T., Webster, M. A., Schaller, M., Parsons, T. J., Cardiff, R. D., & Muller, W. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10578 · Cited by 1,193
TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression
Yang, L., Pang, Y., & Moses, H. L. (2010) · Trends in Immunology · doi:10.1016/j.it.2010.04.002 · Cited by 1,023
New signals from the invasive front
Christofori, G. (2006) · Nature · doi:10.1038/nature04872 · Cited by 993
In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer
Pagès, F., Kirilovsky, A., Mlecnik, B., Asslaber, M., Tosolini, M., Bindea, G., Lagorce, C., Wind, P., Marliot, F., Bruneval, P., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.6147 · Cited by 954
The polarization of immune cells in the tumour environment by TGFβ
Flavell, R. A., Sanjabi, S., Wrzesinski, S. H., & Licona-Limón, P. (2010) · Nature Reviews Immunology · doi:10.1038/nri2808 · Cited by 940
REGULATION OF IMMUNE RESPONSES THROUGH INHIBITORY RECEPTORS
Long, E. O. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.875 · Cited by 939
RECEPTORS FOR HLA CLASS-I MOLECULES IN HUMAN NATURAL KILLER CELLS
Moretta, A., Bottino, C., Vitale, M., Pende, D., Biassoni, R., Mingari, M. C., & Moretta, L. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.619 · Cited by 875
Self-citationSmyth, M. J., Dunn, G. P., & Schreiber, R. D. (2006) · Advances in Immunology · doi:10.1016/s0065-2776(06)90001-7 · Cited by 870
Gobert, M., Treilleux, I., Bendriss-Vermare, N., Bachelot, T., Goddard-Leon, S., Arfi, V., Biota, C., Doffin, A. C., Durand, I., Olive, D., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2360 · Cited by 758
Self-citationCastriconi, R., Cantoni, C., Della Chiesa, M., Vitale, M., Marcenaro, E., Conte, R., Biassoni, R., Bottino, C., Moretta, L., & Moretta, A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0730640100 · Cited by 726
Self-citationDighe, A. S., Richards, E., Old, L. J., & Schreiber, R. D. (1994) · Immunity · doi:10.1016/1074-7613(94)90087-6 · Cited by 663
Ruggeri, L., Mancusi, A., Capanni, M., Urbani, E., Carotti, A., Aloisi, T., Stern, M., Pende, D., Perruccio, K., Burchielli, E., et al. (2007) · Blood · doi:10.1182/blood-2006-07-038687 · Cited by 616
Ferlazzo, G., Pack, M., Thomas, D., Paludan, C., Schmid, D., Strowig, T., Bougras, G., Muller, W. A., Moretta, L., & Münz, C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407522101 · Cited by 583
Luci, C., Reynders, A., Ivanov, I. I., Cognet, C., Chiche, L., Chasson, L., Hardwigsen, J., Anguiano, E., Banchereau, J., Chaussabel, D., et al. (2009) · Nature Immunology · doi:10.1038/ni.1681 · Cited by 554
Lee, J.-C., Lee, K.-M., Kim, D.-W., & Heo, D. S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7335 · Cited by 549
Costello, R. T., Sivori, S., Marcenaro, E., Lafage-Pochitaloff, M., Mozziconacci, M.-J., Reviron, D., Gastaut, J.-A., Pende, D., Olive, D., & Moretta, A. (2002) · Blood · doi:10.1182/blood.v99.10.3661 · Cited by 500
Self-citationHuman natural killer cell development
Freud, A. G., & Caligiuri, M. A. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00451.x · Cited by 497
Romagnani, C., Juelke, K., Falco, M., Morandi, B., D’Agostino, A., Costa, R., Ratto, G., Forte, G., Carrega, P., Lui, G., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.4947 · Cited by 494
Self-citationDendritic Cell Infiltration and Prognosis of Early Stage Breast Cancer
Treilleux, I., Blay, J.-Y., Bendriss-Vermare, N., Ray-Coquard, I., Bachelot, T., Guastalla, J.-P., Bremond, A., Goddard, S., Pin, J.-J., Barthelemy-Dubois, C., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0684 · Cited by 460
Moretta, A., Sivori, S., Vitale, M., Pende, D., Morelli, L., Augugliaro, R., Bottino, C., & Moretta, L. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.3.875 · Cited by 447
Self-citationEvidence for discrete stages of human natural killer cell differentiation in vivo
Freud, A. G., Yokohama, A., Becknell, B., Lee, M. T., Mao, H. C., Ferketich, A. K., & Caligiuri, M. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052507 · Cited by 443
CD4+CD25+ T Regulatory Cells Suppress NK Cell-Mediated Immunotherapy of Cancer
Smyth, M. J., Teng, M. W. L., Swann, J., Kyparissoudis, K., Godfrey, D. I., & Hayakawa, Y. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1582 · Cited by 420
Romagné, F., André, P., Spee, P., Zahn, S., Anfossi, N., Gauthier, L., Capanni, M., Ruggeri, L., Benson, D. M., Blaser, B. W., et al. (2009) · Blood · doi:10.1182/blood-2009-02-206532 · Cited by 408
Self-citationChiesa, M. D., Carlomagno, S., Frumento, G., Balsamo, M., Cantoni, C., Conte, R., Moretta, L., Moretta, A., & Vitale, M. (2006) · Blood · doi:10.1182/blood-2006-03-006700 · Cited by 399
Self-citationFauriat, C., Just-Landi, S., Mallet, F., Arnoulet, C., Sainty, D., Olive, D., & Costello, R. T. (2007) · Blood · doi:10.1182/blood-2005-08-027979 · Cited by 380
Self-citationImmune-Induced Epithelial to Mesenchymal Transition In vivo Generates Breast Cancer Stem Cells
Santisteban, M., Reiman, J. M., Asiedu, M. K., Behrens, M. D., Nassar, A., Kalli, K. R., Haluska, P., Ingle, J. N., Hartmann, L. C., Manjili, M. H., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3343 · Cited by 379
Carrega, P., Morandi, B., Costa, R., Frumento, G., Forte, G., Altavilla, G., Ratto, G. B., Mingari, M. C., Moretta, L., & Ferlazzo, G. (2008) · Cancer · doi:10.1002/cncr.23239 · Cited by 379
Patel, S. A., Meyer, J. R., Greco, S. J., Corcoran, K. E., Bryan, M., & Rameshwar, P. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903143 · Cited by 363
Arteaga, C. L., Hurd, S. D., Winnier, A. R., Johnson, M. D., Fendly, B. M., & Forbes, J. T. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116871 · Cited by 359
Lakshmikanth, T., Burke, S., Ali, T. H., Kimpfler, S., Ursini, F., Ruggeri, L., Capanni, M., Umansky, V., Paschen, A., Sucker, A., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36022 · Cited by 347
Breast Cancer Lung Metastasis Requires Expression of Chemokine Receptor CCR4 and Regulatory T Cells
Olkhanud, P. B., Baatar, D., Bodogai, M., Hakim, F., Gress, R., Anderson, R. L., Deng, J., Xu, M., Briest, S., & Biragyn, A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4619 · Cited by 312
Gene Expression Profiling Shows Medullary Breast Cancer Is a Subgroup of Basal Breast Cancers
Bertucci, F., Finetti, P., Cervera, N., Charafe-Jauffret, E., Mamessier, E., Adélaïde, J., Debono, S., Houvenaeghel, G., Maraninchi, D., Viens, P., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0031 · Cited by 310
Self-citationConfirmation of a prognostic index in primary breast cancer
Todd, J., Dowle, C., Williams, M., Elston, C., Ellis, I., Hinton, C., Blamey, R., & Haybittle, J. (1987) · British Journal of Cancer · doi:10.1038/bjc.1987.230 · Cited by 308
Berg, M., Lundqvist, A., McCoy, P., Samsel, L., Fan, Y., Tawab, A., & Childs, R. (2009) · Cytotherapy · doi:10.1080/14653240902807034 · Cited by 304
A gene expression signature identifies two prognostic subgroups of basal breast cancer
Sabatier, R., Finetti, P., Cervera, N., Lambaudie, E., Esterni, B., Mamessier, E., Tallet, A., Chabannon, C., Extra, J.-M., Jacquemier, J., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0897-9 · Cited by 290
Self-citationSurface NK receptors and their ligands on tumor cells
Moretta, L., Bottino, C., Pende, D., Castriconi, R., Mingari, M. C., & Moretta, A. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.03.002 · Cited by 283
Self-citationAmerican Joint Committee on Cancer Prognostic Factors Consensus Conference
Yarbro, J. W., Page, D. L., Fielding, L. P., Partridge, E. E., & Murphy, G. P. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991201)86:11<2436::aid-cncr35>3.0.co;2-# · Cited by 266
Natural Killer Cell-Mediated Killing of Freshly Isolated Neuroblastoma Cells
Castriconi, R., Dondero, A., Corrias, M. V., Lanino, E., Pende, D., Moretta, L., Bottino, C., & Moretta, A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2682 · Cited by 259
Self-citationMature natural killer cells reset their responsiveness when exposed to an altered MHC environment
Joncker, N. T., Shifrin, N., Delebecque, F., & Raulet, D. H. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100570 · Cited by 259
Epling-Burnette, P. K., Bai, F., Painter, J. S., Rollison, D. E., Salih, H. R., Krusch, M., Zou, J., Ku, E., Zhong, B., Boulware, D., et al. (2007) · Blood · doi:10.1182/blood-2006-07-035519 · Cited by 232
Elliott, J. M., Wahle, J. A., & Yokoyama, W. M. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100986 · Cited by 225
Alexe, G., Dalgin, G. S., Scanfeld, D., Tamayo, P., Mesirov, J. P., DeLisi, C., Harris, L., Barnard, N., Martel, M., Levine, A. J., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0539 · Cited by 207
McGilvray, R. W., Eagle, R. A., Watson, N. F. S., Al-Attar, A., Ball, G., Jafferji, I., Trowsdale, J., & Durrant, L. G. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0991 · Cited by 196
Demotte, N., Wieërs, G., Van Der Smissen, P., Moser, M., Schmidt, C., Thielemans, K., Squifflet, J.-L., Weynand, B., Carrasco, J., Lurquin, C., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0761 · Cited by 179
The prognostic value of natural killer cell infiltration in resected pulmonary adenocarcinoma
Takanami, I., Takeuchi, K., & Giga, M. (2001) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2001.113026 · Cited by 174
Chapter 2 Natural Killer Cell Tolerance
Jonsson, A. H., & Yokoyama, W. M. (2009) · Advances in immunology · doi:10.1016/s0065-2776(08)01002-x · Cited by 168
Different checkpoints in human NK-cell activation
MORETTA, L., BOTTINO, C., PENDE, D., VITALE, M., MINGARI, M., & MORETTA, A. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.008 · Cited by 166
Self-citationFunctional Analysis of Human NK Cells by Flow Cytometry
Bryceson, Y. T., Fauriat, C., Nunes, J. M., Wood, S. M., Björkström, N. K., Long, E. O., & Ljunggren, H. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-362-6_23 · Cited by 155
Total loss of MHC class I is an independent indicator of good prognosis in breast cancer
Madjd, Z., Spendlove, I., Pinder, S. E., Ellis, I. O., & Durrant, L. G. (2005) · International Journal of Cancer · doi:10.1002/ijc.21163 · Cited by 149
Sun, J. C.-Y., Beilke, J. N., Bezman, N., & Lanier, L. L. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20100479 · Cited by 146
López‐Botet, M., Pérez‐Villar, J. J., Carretero, M., Rodríguez, A., Melero, I., Bellón, T., Llano, M., & Navarro, F. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb00949.x · Cited by 144
ADAM-17 Expression in Breast Cancer Correlates with Variables of Tumor Progression
McGowan, P. M., Ryan, B. M., Hill, A. D. K., McDermott, E. W. M., O’Higgins, N. J., & Duffy, M. J. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2092 · Cited by 142
Martinet, L., Jean, C., Dietrich, G., Fournié, J., & Poupot, R. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.05.002 · Cited by 136
Carlsten, M., Baumann, B. C., Simonsson, M., Jädersten, M., Forsblom, A., Hammarstedt, C., Bryceson, Y. T., Ljunggren, H., Hellström‐Lindberg, E., & Malmberg, K. (2010) · Leukemia · doi:10.1038/leu.2010.149 · Cited by 126
Evidence for immune defects in breast and lung cancer patients
Caraș, I., Grigorescu, A. C., Stăvaru, C., Radu, D. L., Mogos, I., Szegli, G., & Sălăgeanu, A. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0556-2 · Cited by 99
Bedel, R., Thiery-Vuillemin, A., Grandclément, C., Balland, J., Rémy-Martin, J., Kantelip, B., Pallandre, J.-R., Pivot, X., Ferrand, C., Tiberghien, P., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-09-4540 · Cited by 99
Prevention of Breast Cancer (Part I): Epidemiology, Risk Factors, and Risk Assessment Tools
Tirona, M. T., Sehgal, R., & Ballester, O. (2010) · Cancer Investigation · doi:10.3109/07357907.2010.494321 · Cited by 86
Kloeß, S., Huenecke, S., Piechulek, D., Esser, R., Koch, J., Brehm, C., Soerensen, J., Gardlowski, T., Brinkmann, A., Bader, P., et al. (2010) · European Journal of Immunology · doi:10.1002/eji.201040568 · Cited by 83
Chansac, B. L. M., Moretta, A., Vergnon, I., Opolon, P., Lécluse, Y., Grunenwald, D. H., Kubin, M. Z., Soria, J., Chouaı̈b, S., & Mami‐Chouaib, F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.5790 · Cited by 81
Self-citationUpregulation of MICA on high-grade invasive operable breast carcinoma.
Madjd, Z., Spendlove, I., Moss, R. S., Bevin, S., Pinder, S. E., Watson, N. F., Ellis, I. O., & Durrant, L. G. (2007) · PubMed Central · Cited by 74
Dewan, M. Z., Terunuma, H., Takada, M., Tanaka, Y., Abé, H., Sata, T., Toi, M., & Yamamoto, N. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9416-4 · Cited by 69
Kute, T. E., Savage, L., Stehle, J., Kim-Shapiro, J. W., Blanks, M. J., Wood, J. C. S., & Vaughn, J. P. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-009-0700-0 · Cited by 69
Cyclooxygenase inhibitors modulate NK activities that control metastatic disease
Kundu, N., Walser, T. C., Ma, X., & Fulton, A. M. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-005-0669-2 · Cited by 68
Antagonism of the prostaglandin E receptor EP4 inhibits metastasis and enhances NK function
Kundu, N., Ma, X., Holt, D. M., Goloubeva, O. G., Ostrand‐Rosenberg, S., & Fulton, A. M. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0180-5 · Cited by 61
Human Activated T Lymphocytes Modulate IDO Expression in Tumors through Th1/Th2 Balance
Godin-Ethier, J., Pelletier, S., Hanafi, L., Gannon, P. O., Forget, M., Routy, J., Boulassel, M., Krzemien, U., Tanguay, S., Lattouf, J., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901004 · Cited by 61
Lin, S., Yang, J. T., Everett, A. D., Clevenger, C. V., Koneru, M., Mishra, P. K., Kamen, B. A., BANERJEE, D., & Glod, J. W. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.07.028 · Cited by 57
Natural killer cells in breast cancer cell growth and metastasis in SCID mice
Dewan, M. Z., Terunuma, H., Ahmed, S., Ohba, K., Takada, M., Tanaka, Y., Toi, M., & Yamamoto, N. (2005) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(05)80082-4 · Cited by 56
Human breast cancer and impaired NK cell function
Garner, W. L., MINTON, J. P., James, A. G., & Hoffmann, C. C. (1983) · Journal of Surgical Oncology · doi:10.1002/jso.2930240115 · Cited by 48
Natural killer activity of peripheral-blood mononuclear cells in breast cancer patients
Dewan, M. Z., Takada, M., Terunuma, H., Deng, X., Ahmed, S., Yamamoto, N., & Toi, M. (2009) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2009.02.003 · Cited by 48
Re-educating natural killer cells
Sun, J. C. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20101748 · Cited by 39
Cited by
The immune contexture in human tumours: impact on clinical outcome
Fridman, W. H., Pagès, F., Sautès-Fridman, C., & Galon, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3245 · Cited by 4,981
Hiam-Galvez, K. J., Allen, B. M., & Spitzer, M. H. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00347-z · Cited by 1,400
NK cells for cancer immunotherapy
Shimasaki, N., Jain, A., & Campana, D. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0052-1 · Cited by 1,222
André, P., Denis, C., Soulas, C., Bourbon-Caillet, C., Lopez, J., Arnoux, T., Bléry, M., Bonnafous, C., Gauthier, L., Morel, A., et al. (2018) · Cell · doi:10.1016/j.cell.2018.10.014 · Cited by 1,221
Self-citationNatural killer cells and other innate lymphoid cells in cancer
Chiossone, L., Dumas, P.-Y., Vienne, M., & Vivier, E. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0061-z · Cited by 1,007
Metadata
- Authors
- Mamessier, E., Sylvain, A., Thibult, M.-L., Houvenaeghel, G., Jacquemier, J., Castellano, R., Gonçalves, A., André, P., Romagné, F., Thibault, G., Viens, P., Birnbaum, D., Bertucci, F., Moretta, A., & Olive, D.
- Venue
- Journal of Clinical Investigation
- Published
- 2011-09-01
- Volume
- 121
- Issue
- 9
- Pages
- 3609-3622
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2141436376
- Cited by
- 681
- References
- 87
- FWCI
- 10.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.